Gut microbiome affects the response to immunotherapy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1149, doi. 10.1111/1759-7714.15303
- By:
- Publication type:
- Article
Works matching IS 17597706 AND DT 2024 AND VI 15 AND IP 14
Results: 10
1
2
Immune cell‐related prognostic risk model and tumor immune environment modulation in esophageal carcinoma based on single‐cell and bulk RNA sequencing.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1176, doi. 10.1111/1759-7714.15301
- By:
- Publication type:
- Article
3
Identification of a risk score model based on tertiary lymphoid structure‐related genes for predicting immunotherapy efficacy in non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1119, doi. 10.1111/1759-7714.15299
- By:
- Publication type:
- Article
4
Correction to "Curcumin induces ferroptosis in non‐small‐cell lung cancer via activating autophagy".
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1197, doi. 10.1111/1759-7714.15298
- Publication type:
- Article
5
Surgery challenges and postoperative complications of lung cancer after neoadjuvant immunotherapy.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1138, doi. 10.1111/1759-7714.15297
- By:
- Publication type:
- Article
6
Navigating venous thromboembolism risks in lung cancer patients.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1195, doi. 10.1111/1759-7714.15290
- By:
- Publication type:
- Article
7
Considerations for multidisciplinary management of synchronous primary breast cancer and primary lung cancer – Analysis of thirty‐one patients.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1132, doi. 10.1111/1759-7714.15284
- By:
- Publication type:
- Article
8
Single‐cell RNA sequencing reveals aberrant sphingolipid metabolism in non‐small cell lung cancer impacts tumor‐associated macrophages and stimulates angiogenesis via macrophage inhibitory factor signaling.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1164, doi. 10.1111/1759-7714.15283
- By:
- Publication type:
- Article
9
Quantitative evaluation of the impact of relaxing eligibility criteria on the risk–benefit profile of drugs for lung cancer based on real‐world data.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1187, doi. 10.1111/1759-7714.15269
- By:
- Publication type:
- Article
10
Issue Information.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 14, p. 1117, doi. 10.1111/1759-7714.14957
- Publication type:
- Article